Access to mental healthcare: how should pharma companies channel their efforts?
Suvi Karuranga, Researcher, and Jayasree K. Iyer, Executive Director, share their thoughts and findings on access to mental healthcare with the aim of starting a conversation about how manufacturers’ efforts can be channeled in the best directions, and to identify where more can be done.
Date
10 October 2016
The authors describe the challenges, the medicines and the ways that the pharmaceutical industry is currently engaged with issues surrounding mental health, in the hopes that a clear direction on what actions are needed can be discussed.
The article was published in the Huffington Post.Â